Exclusive Content
New Johnson & Johnson drug authorised in Britain for schizophrenia treatment
In what's seen as a major step forward for the treatment of schizophrenia, the Medicines and Healthcare Products Regulatory Agency (MHRA) has authorized a...
GSK to get $1.25b to settle HIV drug patent row with Gilead
Britain's GlaxoSmithKline (GSK) will receive $1.25 billion (about £921 million) from Gilead Sciences as part of a settlement between its HIV medicines unit and the...
Trial deliberately infecting young adults with Covid found to be safe
The world's first human challenge trial in which volunteers were deliberately exposed to Covid-19 to advance research into the disease was found to be...
Regulatory changes could allow women to access HRT in community pharmacy without prescription
Britain's health regulator is poised to announce that hormone replacement therapy (HRT) will be made available over the counter for the first time, the...
GSK and Pfizer rebuff Unilever’s £50bn bid for consumer healthcare unit
Consumer goods giant Unilever signaled on Monday (January 17) it would pursue a deal for GlaxoSmithKline's (GSK) consumer healthcare business, calling it a "strong strategic...
England to cut minimum Covid self-isolation to five days
The minimum Covid self-isolation period in England will be cut to five days from seven if someone tests negative twice, health secretary Sajid Javid...